Avalon GloboCare Corp. (ALBT)
ALBT Stock Price Chart
Explore Avalon GloboCare Corp. interactive price chart. Choose custom timeframes to analyze ALBT price movements and trends.
ALBT Company Profile
Discover essential business fundamentals and corporate details for Avalon GloboCare Corp. (ALBT) to support your stock research and investment decisions.
Sector
Real Estate
Industry
Real Estate - Services
IPO Date
27 Mar 2018
Employees
4.00
Website
https://www.avalon-globocare.comCEO
David K. Jin
Description
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.
ALBT Financial Timeline
Browse a chronological timeline of Avalon GloboCare Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$2.02 , while revenue for the quarter reached $350.41K .
Earnings released on 13 May 2025
EPS came in at -$1.43 , while revenue for the quarter reached $349.80K .
Earnings released on 31 Mar 2025
EPS came in at -$1.99 , while revenue for the quarter reached $345.77K .
Earnings released on 12 Nov 2024
EPS came in at -$1.82 , while revenue for the quarter reached $345.16K .
Stock split effective on 28 Oct 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 19 Aug 2024
EPS came in at -$2.85 , while revenue for the quarter reached $327.89K .
Earnings released on 30 May 2024
EPS came in at -$1.80 , while revenue for the quarter reached $314.59K .
Earnings released on 15 Apr 2024
EPS came in at -$13.49 , while revenue for the quarter reached $321.32K .
Earnings released on 14 Nov 2023
EPS came in at -$2.10 , while revenue for the quarter reached $331.29K .
Earnings released on 14 Aug 2023
EPS came in at -$3.75 , while revenue for the quarter reached $306.91K .
Earnings released on 22 May 2023
EPS came in at -$4.20 , while revenue for the quarter reached $296.17K .
Earnings released on 30 Mar 2023
EPS came in at -$0.30 , while revenue for the quarter reached $296.33K .
Stock split effective on 5 Jan 2023
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2022
EPS came in at -$9.00 , while revenue for the quarter reached $317.39K .
Earnings released on 30 Jun 2022
EPS came in at -$0.29 , while revenue for the quarter reached $290.82K .
Earnings released on 31 Mar 2022
EPS came in at -$0.23 , while revenue for the quarter reached $297.63K .
Earnings released on 31 Dec 2021
EPS came in at -$0.27 , while revenue for the quarter reached $334.20K .
Earnings released on 30 Sept 2021
EPS came in at -$0.24 , while revenue for the quarter reached $486.76K .
Earnings released on 30 Jun 2021
EPS came in at -$0.28 , while revenue for the quarter reached $280.23K .
Earnings released on 31 Mar 2021
EPS came in at -$0.28 , while revenue for the quarter reached $289.77K .
Earnings released on 31 Dec 2020
EPS came in at -$0.39 , while revenue for the quarter reached $454.56K .
Earnings released on 30 Sept 2020
EPS came in at -$0.40 , while revenue for the quarter reached $324.98K .
ALBT Stock Performance
Access detailed ALBT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.